Ani Pharmaceuticals reported $55.62M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 10036M 518M
Aerie Pharmaceuticals AERI:US $ 61.69M 3M
Ani Pharmaceuticals ANIP:US $ 55.62M 8.56M
Aurora Cannabis Inc ACB:CN 100.9M 107.16M
Biodelivery Sciences International BDSI:US $ 25.47M 4.6M
Canopy Growth Corp WEED:CN C$ 346.73M 20.47M
Depomed DEPO:US $ 19.54M 17.84M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Emergent Biosolutions EBS:US $ 363.7M 19.3M
Endo International Ordinary Shares ENDP:US $ 682.87M 112.15M
Flexion Therapeutics FLXN:US $ 44.98M 73K
Heron Therapeutics HRTX:US $ 74.94M 7.97M
Hikma Pharmaceutical HIK:LN 873M 27M
Knight Therapeutics Inc GUD:CN C$ 69.23M 3.63M
Lannett LCI:US $ 109.67M 30.16M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Novartis NVS:US 10.13B 319M
Omeros OMER:US $ 48.26M 4.58M
Perrigo Ordinary Shares PRGO:US $ 604.4M 502.6M
Sun Pharmaceuticals SUNP:IN IR 74500.1M 6618.2M
Teva Pharmaceutical TEVA:IT 3.26B 64M
Teva Pharmaceutical Industries TEVA:US 3.26B 64M